Fierce2014

FierceHealthcare Innovation Awards Announces Finalists, QPID Health Recognized

QPID Health Recognized by Distinguished Panel of Healthcare CIOs

Boston – November 25, 2014 – QPID Health announced today that is has been selected as a finalist in this year’s Fierce Innovation Awards: Healthcare Edition, an awards program from the publisher of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare. The Company’s Q-Guide product is recognized as a finalist in the category of Clinical Information Management. Finalists were selected by a distinguished panel of CIOs from renowned U.S. hospitals and healthcare systems, including Allina Health, Rush University Medical Center, Mayo Clinic and JFK Health System. A complete list of judges can be found at: https://www.fierceinnovationawards.com/healthcare/2014/judges. The Fierce Innovation Awards recognize pioneering technologies and solutions that will catapult healthcare delivery into new realms. “Our finalists represent the exciting innovation happening in the healthcare industry today,” said Wendy Johnson, FierceMarkets’ healthcare group publisher. “These companies have developed game-changing technologies and solutions that can improve safety, efficiency and patient outcomes.” All applications were evaluated based on the following criteria: quality of care and patient outcomes, care efficiency, financial impact, market validation and overall innovative “fierceness.” Finalists were selected based on calculation of the judges’ scores in each area. Mike Doyle, CEO of QPID Health, comments: “We’re proud to have been selected as a finalist in this year’s Fierce Innovation Awards in the Clinical Information Management category for our product Q-Guide, which we developed in collaboration with Partners HealthCare. Overuse of tests and procedures costs an estimated $46 billion annually here in the U.S. Q-Guide was designed to address that issue. Ensuring appropriate use is important for patient care and is imperative for healthcare providers that are accountable for improving clinical outcomes while reducing care costs. With Q-Guide, we combine best practice guidelines with the patient’s own health information, using our unique ability to pry concepts from structured and unstructured data stored in medical records. To learn more about QPID Health, visit http://dev.qpidhealth.com/ About FierceMarkets FierceMarkets, a wholly owned subsidiary of Questex Media Group, is a leader in B2B emedia, providing information and marketing services in the telecommunications, life sciences, healthcare, IT, energy, government, finance, and retail industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets’ wide array of publications reaches more than 1.3 million executives in more than 100 countries. Current publications include: Energy: FierceEnergy; FierceSmartGrid; Smart Grid News Healthcare: FierceEMR; FierceHealthcare; FierceHealthFinance; FierceHealthIT; FierceHealthPayer; FierceHealthPayerAnti-Fraud; FierceMedicalImaging; FierceMobileHealthcare; FiercePracticeManagement; Hospital Impact Telecom: FierceWireless; FierceCable; FierceDeveloper; FierceOnlineVideo; FierceTelecom; FierceWirelessTech; FierceWireless:Europe / TelecomsEMEA, Telecom Asia; Life Sciences:FierceBiotech; FierceBiotechIT; FierceBiotech Research; FierceCRO; FierceDiagnostics, FierceDrugDelivery; FierceMedicalDevices; FiercePharma; FiercePharmaMarketing; FiercePharmaManufacturing; FierceVaccines; FierceAnimalHealth Enterprise IT: FierceBigData; FierceCIO; FierceCIO:TechWatch; FierceContentManagement; FierceMobileIT; FierceEnterpriseCommunications; Finance: FierceCFO; FierceFinanceIT; Government: FierceGovernment; FierceGovernmentIT; FierceHomelandSecurity; FierceMobileGovernment; Marketing & Retail: FierceCMO; FierceMobileMarketer; FierceMobileRetail; FierceRetail; and FierceRetailIT. About QPID Health QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. QPID extracts patient information from the EHR using natural language processing and machine learning. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital and usage spread virally throughout the Partners HealthCare system including to Brigham & Women’s Hospital, Faulkner and Newton-Wellesley. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Usage has grown from 4000 to 7000 active users over the past year supporting 3 million clinical encounters. Investors include Cardinal Partners, Matrix Partners, Massachusetts General Physicians Organization, New Leaf Venture Partners, and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information. Media Contact: Ceara O’Sullivan NextStep Communications ceara@nextstepcomms.com (315) 567-2528

qpid-logo

QPID Health Appoints Afik Gal as Vice President of Product Innovation

QPID Health Further Strengthens Clinical and Leadership Team

Boston – November 18, 2014 – QPID Health, a leader in clinical intelligence software, today announced that Afik Gal, MD, MBA has joined the Company as VP of Product Innovation. An expert in healthcare analytics, digital health, and data mining, Dr. Gal brings over a decade of experience in healthcare product development and consulting to QPID Health. Dr. Gal’s role will be key in steering the Company’s next generation of products as QPID Health expands across provider, payer and consumer markets. Prior to joining QPID Health, Dr. Gal was with PWC Consulting in the Healthcare Innovation and Healthcare Incubation Lab in Boston, where he advised clients in healthcare, technology, pharmacy, and biotech on strategy and new business. Previously, Dr. Gal founded and led a boutique consulting firm and a healthcare analytics startup company. Dr. Gal holds an MBA from Duke University and an MD from Ben-Gurion University in Israel. “Afik brings a unique background to our leadership team,” said Mike Doyle, QPID Health Chief Executive Officer. “His medical training and clinical experience combined with his expertise in technology design, development, and implementation – as well as healthcare business models – make him an excellent fit for our organization’s next phase of growth.” “Clinicians—including physicians and nurses—are an important part of our team,” explained Doyle. “Our customers benefit from their deep knowledge of the challenges of patient care, as well as their medical subject matter expertise. We employ clinicians in our content development, account management, support and product development functions.” “I’m honored to join QPID Health as VP of product innovation,” says Dr. Gal. “As the healthcare industry becomes more and more data-driven, I see a tangible need for support from technology solutions like QPID. QPID Health has the potential to revolutionize the ways clinicians interact with clinical data at the point-of-care. I look forward to collaborating with the team in place as we work to improve upon the healthcare delivery successes we enable.” About QPID Health QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. QPID extracts patient information from the EHR using natural language processing and machine learning. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital and usage spread virally throughout the Partners HealthCare system including to Brigham & Women’s Hospital, Faulkner and Newton-Wellesley. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Usage has grown from 4000 to 7000 active users over the past year supporting 3 million clinical encounters. Investors include Cardinal Partners, Matrix Partners, Massachusetts General Physicians Organization, New Leaf Venture Partners, and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information. Media Contact: Ceara O’Sullivan NextStep Communications ceara@nextstepcomms.com (315) 567-2528

qpid-logo

QPID Health Appoints Jim Dowling as Vice President of Sales

Company Continues to Strengthen Management Team with Experienced Industry Veteran

Boston – September 25, 2014 – QPID Health, a leader in clinical intelligence software, today announced that Jim Dowling has joined the Company as vice president of sales. Mr. Dowling brings a wealth of experience in healthcare information technology sales and business management and will apply this background to assist QPID Health in its rapid expansion.  Mr. Dowling will be based out of the Company’s headquarters in Boston.

Prior to joining QPID Health, Mr. Dowling served as the executive vice president of enterprise, self-service solutions at QuadraMed Corporation, where he played a key role in the sale of the company. Prior to QuadraMed, Mr. Dowling worked at NCR Healthcare, serving as general manager and vice president of sales. He handled operations for the company’s entire product suite. Additionally, Mr. Dowling has held a variety of senior sales and management positions at GE Healthcare IT/IDX Systems, including general manager of the imaging solutions division. Mr. Dowling holds a Bachelor of Science in Marketing from the New York Institute of Technology.

QPID addresses the data overload and lack of usability of EHRs, which make doctors, nurses and other clinicians less productive and can obscure critical patient health factors. QPID automatically extracts the essential patient narrative from structured and unstructured data scattered throughout the patient record. Pertinent patient data is packaged and delivered directly to clinicians, ensuring that decisions are made with the best available information. QPID Health raised $12.3m in Series B funding in May to meet the market demand for its solutions. QPID currently supports over 6,000 active clinical users, up from 4,000 at the end of 2013, its first year of commercial operation.

“At a time when the interest in our solutions is gaining momentum, Jim understands the pain that clinicians are facing just trying to do their jobs and believes QPID will greatly assist in this effort,” said Mike Doyle, QPID Health chief executive officer. “Hospitals are striving for ways to better incorporate their electronic health records into their workflow and are turning to our solutions to facilitate the transformation. With Jim on our team, our company is well positioned to handle the expanding market and to serve our customers with excellence.”

“I’m honored to be joining QPID as the Vice President of Sales,” says Mr. Dowling. “I’m pleased to support our customers through initial technology investments in enterprise EHRs, to a clinical and revenue cycle ROI through the incorporation of QPID’s technology. There is a definite and growing market need for the clinical intelligence that QPID provides. Hospitals and the government have already done the heavy lifting—so to speak—by moving their records from paper to electronic format. I am thrilled to help hospitals take the next step in enabling clinicians to work more efficiently and improve both the health of patients and their bottom line.”

About QPID Health

QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital (MGH) and usage spread virally throughout the Partners HealthCare system hospitals and affiliates including Brigham & Women’s Hospital, Dana-Farber Cancer Institute, Faulkner, Newton-Wellesley Hospital, and North Shore Hospital as well as MGH. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Investors include Matrix Partners, Cardinal Partners, New Leaf Venture Partners, Massachusetts General Physicians Organization and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.

Media Contact:

Ceara O’Sullivan
NextStep Communications
ceara@nextstepcomms.com
(315) 567-2528

qpid-logo

QPID Health Announces Major Office Expansion in Boston and Opens Facility in San Diego

The Company’s Growth Necessitates Additional Space and Staff to Facilitate Product Development and Service Customers Nationwide

Boston – September 16, 2014 – QPID Health, a leader in clinical intelligence software, today announced a move to new headquarters in Boston and their first West Coast location in San Diego.  The new headquarters at 175 Federal Street in Boston will house product development, engineering, operations and marketing teams. QPID Health’s new Southern California office will be located at 1000 Aviara Parkway in Carlsbad.  The expansion was needed in order to meet the demands of customers nationwide. Both new locations will be operational at the end of October.

The QPID software platform enables healthcare providers to get the most from their investment in electronic health records (EHRs) by delivering relevant patient information where and when it is needed. EHRs are difficult to use and waste valuable clinician time because of the high volume of data they contain and because they are not organized the way clinicians think. QPID solves that problem.

QPID Health formally launched in late 2012. Since raising $12.3M in venture funding as part of the Company’s Series B earlier this year, the Company has invested in product development and services to further the core mission of ‘Improving Healthcare’. Moving to new space is imperative to support the Company’s growth.

“Our move to a larger Boston headquarters, opening of the San Diego facility, and our willingness to embrace remote employee arrangements underscore our commitment to hiring the best available people, no matter where they are located,” explained Mike Doyle, President & CEO of QPID Health. “I’m grateful for the passion of my team and look forward to our move, as it affords us the ability to further develop our technology and work toward improved clinical care.”

In 2013, QPID Health’s first year of commercial operation, 4,000 active users generated nearly 3 million clinical encounters with QPID’s platform at Partners HealthCare hospitals including Massachusetts General Hospital and Brigham & Women’s Hospital. Today, over 6,000 active users are benefiting from QPID solutions, both within and outside of the Partners network.

About QPID Health

QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital (MGH) and usage spread virally throughout the Partners HealthCare system hospitals and affiliates including Brigham & Women’s Hospital, Dana-Farber Cancer Institute, Faulkner, Newton-Wellesley Hospital, and North Shore Hospital as well as MGH. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Investors include Matrix Partners, Cardinal Partners, New Leaf Venture Partners, Massachusetts General Physicians Organization and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.

Media Contact:

Ceara O’Sullivan
NextStep Communications
ceara@nextstepcomms.com
(315) 567-2528

qpid-logo

QPID Health Appoints David Burke as Chief Financial Officer

Company strengthens its leadership team with healthcare industry veteran

Boston – August 15, 2014 – QPID Health, the leader in clinical intelligence software that enables healthcare providers to get the most from their investment in electronic health records, HIEs or any data warehouse, today announced that David Burke has joined the company as Chief Financial Officer. Mr. Burke brings deep experience in healthcare, finance, operations, and corporate strategy and will play an influential role as QPID Health continues its rapid expansion in hospital, provider, and other healthcare markets.

Prior to joining QPID Health Mr. Burke served as Chief Operating Officer and CFO of GNS Healthcare, whose big data analytics platform empowers the development of targeted drugs and clinical interventions. While at GNS, Burke and his colleagues helped the firm raise $15 million in strategic equity, develop core operational and financial competencies, and expand into new products and markets. Previously Mr. Burke served as CFO of patient-reported-outcomes leader QualityMetric, where he helped the company enhance execution and accelerate growth leading to its successful acquisition by Ingenix (now OptumInsight). Earlier in his career Mr. Burke served as CFO or senior financial manager of companies serving medical device, product development, senior housing, technology, and other industries. Mr. Burke is a graduate of Harvard College and holds an MBA from Columbia University Graduate School of Business.

QPID addresses the data overload and lack of usability of EHRs, which make doctors, nurses and other clinicians less productive and can obscure critical patient health factors. QPID automatically extracts the essential patient narrative from structured and unstructured data scattered throughout the patient record. Pertinent patient data is packaged and delivered directly to clinicians, ensuring that decisions are made with the best available information. QPID Health raised $12.3m in Series B funding in May to meet the market demand for its solutions. QPID supported 5000 active clinical users in Q1 2014, up from 4000 at the end of 2013, its first year of commercial operation.

“David brings a wealth of executive skill, financial savvy and industry knowledge to this position,” said Mike Doyle, QPID Health Chief Executive Officer. “He has the acumen needed to understand the challenges of healthcare providers who are dealing with changes in the economics of healthcare as well as government mandates, and how information technology like QPID can help address those issues.  David supports our mission to drive more efficient and improved care, which is the foundation of our corporate culture and goals.”

“I’m very pleased to be joining QPID Health as CFO,” says Mr. Burke. “The size and sophistication of the global EHR market is exploding and hospitals, health systems and clinicians are under mounting pressure to deliver informed, effective care to their patients. QPID’s proven technology revolutionizes the rapid discovery and visualization of rich, actionable clinical insights to support efficient healthcare delivery and improved patient outcomes.”

About QPID Health

QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital and usage spread virally throughout the Partners HealthCare system and its 9 hospitals. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Investors include Matrix Partners, Cardinal Partners, New Leaf Venture Partners, Massachusetts General Physicians Organization and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.

Media Contact:

Ceara O’Sullivan
NextStep Communications
ceara@nextstepcomms.com
(315) 567-2528

qpid-logo

QPID Health Secures $12.3M Series B Funding

New Leaf Venture Partners leads round to accelerate company’s growth and meet market demand for its clinical intelligence solution  

Boston – May 6, 2014 – QPID Health, which has committed to bringing clinical intelligence to healthcare providers to improve outcomes and lower costs, today announced a $12.3M Series B round of funding led by New York City-based New Leaf Venture Partners. The company will use the investment to meet the market demand for its clinical intelligence solution, which promotes cost-effective and high quality patient care by making it easy for clinicians get access to patient data stored in electronic health records (EHRs) and other backend data repositories. The QPID software, which sits on top of virtually any EHR, has proven that it can generate a strong ROI for hospitals and physician practices. QPID Health welcomes New Leaf’s Managing Director Philippe Chambon to its board of directors.

Today’s investment enables QPID to accelerate the growth of the company and support wider use of its proven software solution in leading hospitals and healthcare systems in the U.S. Current customers include Massachusetts General and Brigham & Women’s Hospitals as well as other members of the Partners HealthCare system. Implementations in other leading medical centers across the country are under way.

“We are seeing high demand for the QPID solution because it provides a truly clinician-friendly interface that is built on the rich data in EHRs but is presented in a way that makes sense to users and eliminates the noise,” said QPID Health CEO Mike Doyle. “Knowledge of the patient’s relevant history – including diagnoses, procedures, test results and potential safety concerns – is essential for making choices that are good for the patient. Further, QPID’s unique ability to activate complex guidelines and models in the moment, for the clinical trench, also helps hospitals eliminate waste and use resources wisely. Although health systems have invested millions of dollars in electronic health records, it’s clear that more data does not mean more efficiency. With QPID, healthcare providers can optimize the value of the digital data that they’ve captured in EHRs because of our unique ability to aggregate the right information and deliver it at the right time.”

Philippe Chambon, Managing Director of New Leaf Venture Partners, said: “QPID’s solution addresses a major challenge for physicians who must access patient information at the point of care. This allows physicians to regain control of their workflow and facilitates their ability to interact with patients. QPID is the clear leader in this space and I am excited to work with the company as they rapidly advance their commercialization efforts.”

In a scalable cloud-based architecture, QPID uses advanced concept-based natural language processing (NLP) to extract clinical intelligence from data stored in EHR systems and other clinical repositories. In 2013, its first year of commercial operation, the company supported a steadily growing user base, ending the year with 4,000 active clinical users, representing 2.96M clinical encounters and impacting 340,000 patients. In the first quarter of 2014 usage has grown to nearly 5,000 clinician users.

This financing round was led by New Leaf Venture Partners and supported by all investors who participated in the Series A round. The company previously raised a $4.4 million Series A round which closed in March 2013 from Cardinal Partners, Matrix Partners, the Massachusetts General Physicians Organization (MGPO) and Partners Innovation Fund.

About New Leaf Venture Partners

New Leaf Venture Partners is a leading healthcare technology venture firm.  We invest broadly across healthcare-related information technology companies as well as both public and private biopharmaceutical companies.

New Leaf currently manages two funds: New Leaf Ventures I, L.P., and New Leaf Ventures II, L.P. (NLV-II), as well as the healthcare technology portfolio of the Sprout Group, one of the oldest U.S. venture capital fund groups.  New Leaf’s current active fund, NLV-II, has committed $80 million to companies in the healthcare IT sector and $270 million to firms in the biopharmaceutical sector.  For more information please visit http://www.nlvpartners.com.

About QPID Health

QPID Health’s clinical intelligence software automatically delivers relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The QPID solution was developed at Massachusetts General Hospital and usage spread virally throughout the Partners HealthCare system. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. Investors include Cardinal Partners, Matrix Partners, Massachusetts General Physicians Organization, New Leaf Venture Partners, and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.

Media Contact:

Nigel Smith
NextStep Communications
nigel@nextstepcomms.com
(781) 308-3317

qpid-logo

QPID Health Announces Formation of Advisory Board

Group of nationally recognized healthcare IT and policy leaders to provide strategic guidance 

Boston – April 23, 2014 – QPID Health, an innovative provider of clinical intelligence software solutions, today announced the formation of the Company’s first industry Advisory Board, which will provide insights on the concerns of healthcare leaders and guidance on corporate and product strategy. In the last year, the company has rolled out new products and expanded its customer and employee bases.

“Today, EHRs have proven to be great repositories for data, but physicians and other clinicians still struggle to gain what’s clinically relevant from the data they hold,” said Mike Doyle, QPID Health chief executive officer. “QPID Health solves that problem by unlocking value from the data within existing EHRs. In our evolving outcomes-based health economy, QPID’s technology is helping drive more efficient and improved care. We are thrilled to have attracted this group of industry thought leaders who share our passion for helping clinicians deliver the best possible care to patients.”

With the global EHR market expected to reach $22.3 billion by the end of 2015, the board will help QPID solidify its place in the market in order to serve the massive demand from hospitals and health systems looking to leverage EHRs in new and measureable ways. Passionate practicing physicians created the Company’s platform as part of a Massachusetts General Hospital informatics initiative in 2005 and QPID Health officially launched in 2012. True to its roots, development teams are led by doctors to address the practical concerns of users in the clinical environment.

Through its scalable cloud-based architecture, QPID leverages advanced concept-based natural language processing (NLP) to extract insights from data stored in EHR systems and other clinical repositories. In 2013, its first year of commercial operation, the company supported a growing user base ending the year with 4000 active quarterly users, and 2.96 million clinical encounters impacting 340,000 patients.

QPID Health advisory board members:

David W. Bates, MD, MSc is Chief of the Division of General Internal Medicine and Primary Care at Brigham and Women’s Hospital, Professor of Medicine at Harvard Medical School, and Professor of Health Policy and Management at the Harvard School of Public Health, where he co-directs the Program in Clinical Effectiveness.

John D. Halamka, MD, MS is a Professor of Medicine at Harvard Medical School and Chief Information Officer of Beth Israel Deaconess Medical Center, responsible for all clinical, financial, administrative and academic information technology serving 3000 doctors, 14000 employees and two million patients. He is also Chairman of the New England Healthcare Exchange Network (NEHEN), co-Chair of the national HIT Standards Committee, co-Chair of the Massachusetts HIT Advisory Committee and a practicing Emergency Physician.

Julia Adler-Milstein, PhD is an Assistant Professor at University of Michigan whose research focuses on policy and management issues related to the use of IT in healthcare delivery. She is an expert in health information exchange, and studies the productivity and efficiency of electronic health records as well as organizational strategies to maximize EHR effectiveness.

John E. Osborn, JD, MIPP is a senior advisor with the international law firm Hogan Lovells, executive in residence with the healthcare group of Warburg Pincus, a regular contributor to Forbes.com and a faculty member at the University of Washington, Seattle. John was general counsel with Fortune 1000 companies Cephalon and US Oncology, and served in the U.S. Department of State and as a member of the U.S. Advisory Commission on Public Diplomacy.

Robert M. Wachter, MD is a Professor of Medicine at the University of California, San Francisco (UCSF), Associate Chairman of UCSF’s Department of Medicine, and Chief of UCSF’s 60-faculty Division of Hospital Medicine. Dr. Wachter coined the term “hospitalist” and is generally considered the academic leader of the hospitalist movement. He is past president of the Society of Hospital Medicine and past chair of the American Board of Internal Medicine.

About QPID Health

QPID Health’s clinical intelligence software automatically delivers the most relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from decisions based on their complete health information, and hospitals gain cost efficiencies. The solution was developed at Massachusetts General Hospital to address the data overload problem engendered by the spread of electronic health records. QPID Health launched in late 2012 to bring the power of QPID to health systems nationwide. The company is venture backed by Cardinal Partners, Matrix Partners, Massachusetts General Physicians Organization (MGPO), and Partners Innovation Fund. Visit www.dev.qpidhealth.com for more information.

Media Contacts:

Nigel Smith
NextStep Communications
nigel@nextstepcomms.com
(781) 308-3317

Amy Krane
amy.krane@dev.qpidhealth.com
617 292 7743, x 122

qpid-logo

QPID Health Announces Release of Q-Guide

Application promotes appropriate use and cuts costs related to pre-authorization and unnecessary surgical procedures.

Boston – February 18, 2014 – QPID Health, an innovative provider of clinical insights software solutions, today announced the release of the procedure decision support application Q-Guide. Based on the QPID clinical insights platform, the application addresses the need for providers to ensure appropriate procedures in order to improve patient care and reduce healthcare costs. The platform was developed jointly by QPID Health, Massachusetts General Hospital (MGH) and the Massachusetts General Hospital Physicians Organization (MGPO).

Used during the pre-operative decision making process, the application helps clinicians apply complex guidelines-based decision criteria to each patient’s individual profile, and generates a recommended approach and risk score. Measurement of procedural appropriate use is a strategic imperative for providers in an era of increasing provider accountability for improving quality while reducing the costs of care.

Q-Guide also can reduce the requirement for costly prior authorization, a labor-intensive process in which payers approve procedures in advance.

Piloted by 150 clinicians at Massachusetts General Hospital, Q-Guide has expedited the management of over 1100 procedures during the first 18 months of adoption.  MGH plans to use Q-Guide for more procedures in the future.   The Q-Guide application is available from QPID Health as part of its suite of applications built on the QPID platform. QPID delivers clinically relevant information from the mass of data stored in electronic patient records to expedite care decisions. QPID Health supports thousands of users across multiple departments at Massachusetts General Hospital and other Partners HealthCare hospitals, among other institutions.  Q-Guide can be accessed via a Web browser and is hosted in the cloud or in a client/server configuration.

“We want to ensure that patients treated by our physicians receive the most appropriate care based on nationally-approved guidelines and the patient’s own unique health status,” explained Timothy Ferris, MD, vice president of Population Health at the MGH/MGPO and Partners HealthCare.  “Physicians can benefit by using a powerful decision support tool and documenting adherence to evidence-based protocols. This is especially important in the context of changing payment models that reward for outcomes not procedures, and under which risk is shared by payers and providers.”

The MGH/MGPO continues to work with their payers to forgo prior authorization requirements for procedures where Q-Guide is in use. Prior authorization, a process in which permission to conduct a procedure is requested of an insurer, imposes a heavy administrative burden for both payers and healthcare providers. Making this step more efficient through systems like Q-Guide cuts costs from both sides of the equation, reducing administrative overhead and overall healthcare costs.

Mike Doyle, CEO of QPID Health, commented, “Through the use and distribution of the QPID platform we help skilled clinicians get access to up–to-date patient insights to make the best care decisions possible.  Q-Guide is an example of a revolutionary clinical application built on the QPID platform that will over the next few years save hospitals, insurance companies and the government millions of dollars in labor costs and time, and greatly facilitate the most appropriate level of care for the patient.”

Q-Guide uses decision-making algorithms that are driven by combining the patient’s clinical evidence with the latest guidelines and personalized risk models.  The first release of the software includes guidelines for high cost, high use and resource-intensive vascular, cardiac, and orthopedic surgical procedures.

About QPID Health

QPID is a clinical insights software solution that automatically delivers the most relevant patient information from electronic health records and other data sources into clinical and administrative workflows. With QPID, clinicians are more productive, patients benefit from personalized decisions, and hospitals gain cost efficiencies. The solution was developed at the Massachusetts General Hospital in Boston to address the persistent problem of too much data that is too hard to find.  QPID Health launched in late 2012 to bring the power of the QPID clinical insights platform to health systems nationwide. The company is venture backed by Matrix Partners, Partners Innovation Fund, Massachusetts General Physicians Organization (MGPO) and Cardinal Partners. Visit www.dev.qpidhealth.com for more information.

Media Contacts:

Nigel Smith
NextStep Communications
nigel@nextstepcomms.com
(781) 308-3317

Amy Krane
amy.krane@dev.qpidhealth.com
617 292 7743, x 122

Fierce-Award-e1387385528878

Fierce Innovation Awards: Healthcare Edition; QPID Receives Top Recognition

Fierce-Award-e1387385528878QPID, Inc. Recognized for leadership in Clinical Information Management; also takes “Best in Show” honors

Boston, MA – December 18, 2013 – QPID, Inc. announced that is has been recognized by this year’s Fierce Innovation Awards: Healthcare Edition, a unique CIO-reviewed awards program from the publishers of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare. QPID, Inc. received top honors in the “Clinical Information Management” category, as well as an overall award of “Best in Show: Best Cost-Saver.”

Wendy Johnson, FierceMarkets’ healthcare group publisher, says, “The Fierce Innovation awards celebrate the companies who are leading the charge to boldly transform healthcare delivery.  We were overwhelmed by the number and the quality of the applications we received.”

Honorees were selected by a distinguished panel of CIOs and other executives from renowned U.S. hospitals and healthcare systems, Inc.luding Mayo Clinic, Boston Children’s Hospital, Memorial Sloan-Kettering Cancer Center, University of Michigan Hospitals and Health Centers, and Beth Israel Deaconess Medical Center. A complete list of judges can be found at www.fierceinnovationawards.com/healthcare/2013/judges.

Winners were selected based on the following criteria:  impact on quality of care and patient outcomes; impact on care efficiency; impact on healthcare information exchange; technology innovation; financial impact; market validation; compatibility with existing health IT systems; end-user experience and overall level of innovation.

QPID, Inc. is being recognized for its innovative, industry-leading product, QPID.

Mike Doyle, President and CEO of QPID, Inc., said: “We are pleased that the judges named QPID as the winner in Clinical Information Management and Best in Show, Best Cost-Saver. As the market evolves towards fully digital patient records, there is untapped opportunity to use clinical information to drive smart decisions that reduce costs and improve safety and outcomes. QPID’s customers have already achieved significant cost savings and productivity improvements by deploying QPID applications across hospital departments and specialties.”

For example, with QPID, the time required to review the critical aspects of a patient’s health record prior to an interventional radiology procedure has been reduced 8 times. Medicine residents and Emergency Department nurses and doctors can now can assess the condition of a patient in minutes and immediately know the results of common workups, as well as the patient’s allergies, medications, prior surgeries and other potentially life-saving facts.  QPID applications for advance screening of patients prior to MRI, endoscopy and other surgical procedures help avoid costly last minute cancellations that leave expensive equipment unused and schedules thrown off.

QPID delivers meaningful, clinically-significant patient information to clinicians and administrators from data stored in electronic patient records – critical information that might otherwise remain buried and go unfound.  By activating this vital information, QPID increases physician productivity, improves patient safety, and drives revenue and cost savings through better decision making.  QPID applications have been built for a variety of departments, including medicine, emergency, radiology, endoscopy, cardiology, anesthesiology and surgery.   The platform can mine both structured and unstructured data, and Inc.orporates thousands of conceptual queries that retrieve pertinent patient history, lab results, symptoms, and potential causes, among other data that helps clinicians to provide the right services to patients. QPID delivers clinical insights that go far beyond results from standard natural language processing, ontological or keyword search.  In addition to supporting direct patient care, the system is used to rapidly identify cohorts for clinical trials, other types of research, and auto-population of registries.

To learn more about QPID, Inc. visit www.dev.qpidhealth.com.

About FierceMarkets
FierceMarkets, a wholly owned subsidiary of Questex Media Group, is a leader in B2B emedia, providing information and marketing services in the telecommunications, life sciences, healthcare, IT, energy, government, finance, and retail industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets’ wide array of publications reaches more than 1.3 million executives in more than 100 countries.

Current publications include: Energy: FierceEnergy; FierceSmartgrid; Telecom: FierceWireless; FierceCable; FierceDeveloper; FierceOnlineVideo; FierceTelecom; FierceWirelessTech; FierceWireless:Europe; Healthcare: FierceEMR; FierceHealthcare; FierceHealthFinance; FierceHealthIT; FierceHealthPayer; FierceMedicalImaging; FierceMobileHealthcare; FiercePracticeManagement; Hospital Impact; Life Sciences: FierceBiomarkers; FierceBiotech; FierceBiotechIT; FierceBiotech Research; FierceCRO; FierceDiagnostics, FierceDrugDelivery; FierceMedicalDevices; FiercePharma; FiercePharmaManufacturing; FierceVaccines; Enterprise IT: FierceBigData; FierceCIO; FierceCIO:TechWatch; FierceContentManagement; FierceITSecurity; FierceMobileIT; FierceEnterpriseCommunications; Finance: FierceCFO; FierceFinance; FierceFinanceIT; Government: FierceGovernment; FierceGovernmentIT; FierceHomelandSecurity; and FierceMobileGovernment; Marketing & Retail:  FierceCMO; FierceMobileRetail; FierceRetail; and StorefrontBacktalk.

About QPID, Inc.
QPID is a clinical insights software solution that was developed at the Massachusetts General Hospital in Boston to make it easier for clinicians to get value from the patient information stored in electronic health records.  QPID, Inc. launched in February of 2013 to bring the power of the QPID clinical insights platform to health systems nationwide. The company is venture backed by Matrix Partners, Partners Innovation Fund, Massachusetts General Physicians Organization (MGPO) and Cardinal Partners. Visit www.dev.qpidhealth.com for more information.

Fierce-Award-e1387385528878

QPID Recognized as Finalist in Fierce Innovation Awards: Healthcare Edition

Boston, MA – December 5, 2013  QPID, Inc. announced today that is has been selected as a finalist in this year’s Fierce Innovation Awards:  Healthcare Edition, an awards program from the publisher of FierceHealthIT, FierceHealthcare, and FierceMobileHealthcare.  QPID, Inc. was recognized as a finalist in the category of Clinical Information Management.

QPID, Inc. was selected as a finalist for its innovative, industry leading product, the QPID clinical intelligence platform.

Finalists were selected by a distinguished panel of CIOs and other executives from renowned U.S. hospitals and healthcare systems, including Mayo Clinic, Boston Children’s Hospital, Memorial Sloan-Kettering Cancer Center, University of Michigan Hospitals and Health Centers and Beth Israel Deaconess Medical Center. A complete list of judges can be found at www.fierceinnovationawards.com/healthcare/2013/judges.

“These finalists are a cross-section of game-changing solutions providers who are helping providers to transform healthcare delivery and improve care,” said Wendy Johnson, FierceMarkets’ healthcare group publisher. “This is truly an exciting time in healthcare. Disruptive changes are happening that will lead to lasting improvements and millions of saved—and improved—lives.”

All applications were evaluated based on the following criteria:  impact on quality of care and patient outcomes; impact on care efficiency; impact on healthcare information exchange; technology Innovation; financial Impact; market validation; compatibility with existing health IT systems; end-user experience and overall level of innovation. Finalists were selected based on the judges’ scores in each area.

Mike Doyle, President and CEO of QPID, Inc. said: “We are pleased that the judges named QPID as a finalist for clinical information management. Clearly they recognize that QPID solves a major problem for providers: How to get the right clinical information into the right hands at the right time, so the best decisions can be made for patients.  Electronic health record systems do a good job of collecting data, but it takes a lot of time and effort to piece together the relevant picture of the patient from the EHR.  By contrast, QPID is designed to rapidly generate and deliver relevant patient summaries that fit the way clinicians diagnose and plan care.”

QPID delivers meaningful, clinically-significant patient information to clinicians and administrators from data stored in electronic patient records – critical information that might otherwise remain buried and go unfound.  By activating this vital information, QPID increases physician productivity, improves patient safety, and drives revenue and cost savings through better decision making.  QPID applications have been built for a variety of departments, including medicine, emergency, radiology, endoscopy, cardiology, anesthesiology and surgery. The platform can mine both structured and unstructured data, and incorporates thousands of conceptual queries that retrieve pertinent patient history, lab results, symptoms, and potential causes, among other data points relevant to diagnosing or planning care. QPID delivers clinical insights that go far beyond results from standard natural language processing, ontological or keyword search. To learn more about QPID, Inc. visit, www.dev.qpidhealth.com.

About FierceMarkets

FierceMarkets, a wholly owned subsidiary of Questex Media Group, is a leader in B2B emedia, providing information and marketing services in the telecommunications, life sciences, healthcare, IT, energy, government, finance, and retail industries through its portfolio of email newsletters, websites, webinars and live events. Every business day, FierceMarkets’ wide array of publications reaches more than 1.3 million executives in more than 100 countries.

Current publications include: Energy: FierceEnergy; FierceSmartgrid; Telecom: FierceWireless; FierceCable; FierceDeveloper; FierceOnlineVideo; FierceTelecom; FierceWirelessTech; FierceWireless:Europe; Healthcare: FierceEMR; FierceHealthcare; FierceHealthFinance; FierceHealthIT; FierceHealthPayer; FierceMedicalImaging; FierceMobileHealthcare; FiercePracticeManagement; Hospital Impact; Life Sciences: FierceBiomarkers; FierceBiotech; FierceBiotechIT; FierceBiotech Research; FierceCRO; FierceDiagnostics, FierceDrugDelivery; FierceMedicalDevices; FiercePharma; FiercePharmaManufacturing; FierceVaccines; Enterprise IT: FierceBigData; FierceCIO; FierceCIO:TechWatch; FierceContentManagement; FierceITSecurity; FierceMobileIT; FierceEnterpriseCommunications; Finance: FierceCFO; FierceFinance; FierceFinanceIT; Government: FierceGovernment; FierceGovernmentIT; FierceHomelandSecurity; and FierceMobileGovernment; Marketing & Retail:  FierceCMO; FierceMobileRetail; FierceRetail; and StorefrontBacktalk.

About QPID, Inc.

QPID is a clinical insights software solution that was developed at the Massachusetts General Hospital in Boston to address the persistent problem of too much data that is too hard to find.  QPID, Inc. launched in February of 2013 to bring the power of the QPID clinical insights platform to health systems nationwide. The company is venture backed by Matrix Partners, Partners Innovation Fund, Massachusetts General Physicians Organization (MGPO) and Cardinal Partners. Visit www.dev.qpidhealth.com for more information.